Supplements for Autonomic Dysfunction and POTS

Postural orthostatic tachycardia syndrome (POTS) is a form of dysautonomia — autonomic nervous system dysfunction — characterized by an excessive heart rate increase upon standing (at least 30 beats per minute within 10 minutes of standing), often with profound orthostatic intolerance, fatigue, brain fog, and pre-syncope. POTS has gained increased recognition after COVID-19, with post-COVID POTS representing a significant subset of new cases. Nutritional and supplement approaches form an important part of the management strategy alongside medications like fludrocortisone, midodrine, and beta-blockers.

Sodium and Fluid Loading: First-Line Intervention

Increased sodium intake is the most foundational and evidence-based non-pharmacological intervention for POTS. The physiological rationale is direct: higher sodium intake expands plasma volume, and POTS patients typically have reduced blood volume (hypovolemia) that underlies their orthostatic symptoms.

The POTS Treatment Center and major dysautonomia organizations recommend 3,000 to 10,000 mg sodium daily for POTS patients, paired with 2 to 3 liters of fluid (preferably electrolyte-containing). This is dramatically higher than standard dietary guidelines and requires physician supervision, particularly in patients with kidney disease, hypertension, or heart failure.

Oral rehydration solutions (containing sodium, potassium, and glucose in physiological ratios) are more effective than water alone for expanding plasma volume because glucose enhances sodium transport in the gut. Commercial POTS-specific electrolyte products or pharmacy-grade oral rehydration salts are commonly used.

Electrolytes: Potassium, Magnesium, and Balance

Alongside sodium, potassium and magnesium maintenance is critical. Fludrocortisone (a mineralocorticoid used for POTS) causes potassium loss, requiring potassium supplementation. Even without fludrocortisone, POTS patients often have electrolyte imbalances from excessive sweating, dysregulated aldosterone, and dietary inadequacy.

Magnesium deficiency is common in POTS and worsens symptoms including tachycardia, muscle cramps, anxiety, and fatigue. Magnesium glycinate 200 to 400 mg daily addresses this deficiency while providing additional nervous system support. Magnesium taurate specifically may support cardiac rhythm stability.

CoQ10: Mitochondrial and Cardiovascular Support

POTS has been linked to mitochondrial dysfunction in several subpopulations, and many patients have documented CoQ10 deficiency. A study by Raj et al. found that POTS patients with documented CoQ10 deficiency showed significant improvement in POTS symptoms when CoQ10 levels were normalized with supplementation.

CoQ10 also improves cardiovascular efficiency, which is relevant given the cardiac demands of POTS. Ubiquinol 200 to 400 mg daily is the preferred form. Combining CoQ10 with L-carnitine addresses complementary aspects of mitochondrial fatty acid metabolism.

Licorice Root (Glycyrrhizin)

Licorice root contains glycyrrhizic acid, which inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11-BHSD2). This enzyme normally converts cortisol to inactive cortisone in kidney tubules. By inhibiting 11-BHSD2, glycyrrhizin allows cortisol to act as a mineralocorticoid, increasing sodium retention and plasma volume — essentially a milder version of fludrocortisone's mechanism.

Clinical reports and small studies show licorice root (as deglycyrrhizinated licorice extract or whole root, typically 250 to 500 mg glycyrrhizin daily) produces meaningful blood pressure elevation and reduced POTS symptoms in hypovolemic patients. The important caveat: licorice can raise blood pressure and lower potassium with chronic use or at high doses. Regular blood pressure and potassium monitoring is required, and patients with hypertension should avoid this approach.

Beta-1,3-Glucan and Immune Support in Post-COVID POTS

Post-COVID POTS appears to involve dysregulated immune activation and autoantibodies against adrenergic and muscarinic receptors. Beta-1,3-glucan and other immune-modulating supplements have been explored in the broader post-COVID context, though specific POTS data is preliminary.

Low-dose naltrexone (LDN) has gained significant interest for autoimmune-mediated dysautonomia, though this is a pharmaceutical intervention rather than a supplement. Addressing underlying immune dysregulation is an active area of research for post-COVID POTS.

FAQ

Q: How much sodium is safe for POTS patients?

The 3,000 to 10,000 mg range recommended for POTS is specific to this population with hypovolemia. This is not appropriate for people without dysautonomia or those with hypertension, kidney disease, or heart failure. A physician evaluation is required before dramatically increasing sodium intake.

Q: Is licorice root safe long-term for POTS?

Long-term use of glycyrrhizin-containing licorice requires monitoring of blood pressure and potassium. Deglycyrrhizinated licorice (DGL) lacks glycyrrhizin and does not have the sodium-retaining mechanism, making it inappropriate for POTS. Only whole licorice or glycyrrhizin-containing products work for POTS.

Q: Can POTS supplements replace medications?

For mild POTS, aggressive sodium loading, hydration, compression garments, and exercise therapy can manage symptoms without medication in some patients. Most moderate to severe POTS requires pharmaceutical support (fludrocortisone, midodrine, or beta-blockers) alongside nutritional management.

Q: Does post-COVID POTS respond differently to supplements?

Post-COVID POTS may have an autoimmune component (autoantibodies, mast cell activation) that responds differently than hyperadrenergic or hypovolemic POTS. Addressing immune triggers (such as mast cell stabilizers or low-dose naltrexone under physician guidance) may be more relevant than purely volume-expanding approaches.

Track your supplements in Optimize.